Snibe become the 1st in China who received FDA Cleared on CLIA product

Release Date:2017-10-27

14th July 2017- Snibe Co., Ltd. receives the FDA clearance on the commercialization of TSH on MaglumiTM 2000 fully-automatic chemiluminescence immunoassay system. (US FDA 510 (k), K NO. : K162698) .It is the 1st company in China who received FDA cleared on CLIA product.

The Food and Drug Administration in US (abbreviated in FDA) is the authority for audit international medicine and also the highest executive departments undertaking the regulation of food and medicine under the authorization of the United States federal executive departments. The major way for medical product to get access to USA market is getting the authorization from FDA.

As one of the global pioneers in IVD field, Snibe have always regarded product quality as the foundation of entrepreneur and getting the approval from FDA is a symbol to explain the great endeavor Snibe have put on the way to pursuit high quality products. This achievement not only means Snibe get the tickets to be able to sell in the US market, but the quality of Snibe products portfolio reached the international advanced level and launch a new era to provide more choices for customers as other top companies. More high-quality products of Snibe are continuing to be declared FDA cleared, and it is supposed more good news is coming soon. 






36棋牌大厅下载 北京快三正规彩票吗 2019女篮比赛赛程 快乐双彩开奖结果查询牛材网 体彩6十1一等奖奖金多少 好运彩彩票app怎么样 彩票合买代购系统 福利彩票3d预测号码准确号码 七星彩开奖结果走势图 澳洲幸运8开奖结果体彩 乐彩网排列五免费预测